Clinical Trials Directory

Trials / Completed

CompletedNCT01739283

GIP and GLP-1 in Type 1 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Mikkel Christensen · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Investigation of Glucose-dependent Insulinotropic Polypeptide (GIP) effects at hyper and hypoglycemia in type 1 diabetes.

Conditions

Interventions

TypeNameDescription
OTHERGIP
OTHERGLP-1
OTHERSaline

Timeline

Start date
2012-07-01
Primary completion
2013-04-01
Completion
2013-11-01
First posted
2012-12-03
Last updated
2015-07-13

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01739283. Inclusion in this directory is not an endorsement.

GIP and GLP-1 in Type 1 Diabetes (NCT01739283) · Clinical Trials Directory